CardieX Limited Financials

CardieX Stock Summary

CardieX competes with NETGEAR, Procter Gamble, Pure Cycle, Kaiser Aluminum, and Axcelis Technologies. CardieX Limited designs, manufactures, and markets medical devices for use in cardiovascular health management in the Americas, Europe, and the Asia Pacific. CardieX Limited was founded in 1994 and is headquartered in Sydney, Australia. Cardiex is traded on OTC Exchange in the United States.

CardieX Key Financial Ratios

Generally speaking, CardieX's financial ratios allow both analysts and investors to convert raw data from CardieX's financial statements into concise, actionable information that can be used to evaluate the performance of CardieX over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that CardieX Limited reports annually and quarterly.

CardieX Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining CardieX's current stock value. Our valuation model uses many indicators to compare CardieX value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CardieX competition to find correlations between indicators driving CardieX's intrinsic value. More Info.CardieX Limited is rated below average in return on equity category among related companies. It is rated below average in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value CardieX by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for CardieX's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CardieX's earnings, one of the primary drivers of an investment's value.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the CardieX Limited information on this page should be used as a complementary analysis to other CardieX's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

If you are still planning to invest in CardieX Limited check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CardieX's history and understand the potential risks before investing.